MedPath

Effect Study for Qizhijiangtang Capsule on Delaying Early Renal Functional Decline in Type 2 Diabetes Patients with Microalbuminuria

Phase 4
Recruiting
Conditions
Microalbuminuria of Diabetic Nephropathy in Patients with Type 2 Diabetes.
Registration Number
ITMCTR1900002359
Lead Sponsor
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) Diagnostic criteria for microalbuminuria in diabetic kidney disease;
(2) Aged 30 to 70 years;
(3) TCM syndrome differentiation is the combination of Qi and Yin;
(4) Sign the patient's informed consent form.

Exclusion Criteria

(1) Combined with serious primary diseases such as cardiovascular, liver, kidney and hematopoietic system, serum transaminase is more than twice the normal value, serum creatinine is greater than the upper limit of normal, and patients with mental illness.
(2) Pregnancy, preparation for pregnancy or lactation, or history of drug allergy.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.